News Releases

FUJIFILM Irvine Scientific Adds Key Products to Life Sciences Portfolio

Additions to sites in Cincinnati, OH, and Bend, OR broaden early development capabilities for oral drug products.

FUJIFILM Irvine Scientific, Inc., a global innovator and manufacturer of cell culture solutions for the Life Sciences, has further expanded its product portfolio and services through the alignment of specific commercial operations with its sister company, FUJIFILM Wako Chemicals U.S.A., Corp. Effective October 1, 2024, products from three divisions within the FUJIFILM Wako Chemicals organization — Lab Automation, Lab Chemicals, LAL Group — will be promoted directly from FUJIFILM Irvine Scientific to customers in the U.S. and Europe.
 
The creation of a single, global commercial organization through FUJIFILM Irvine Scientific, provides an expanded suite of products including cell culture solutions, laboratory chemicals, clinical diagnostic reagents, and laboratory automation software and services.
 
Each company will maintain distinct business operations for product development, manufacturing facilities, and quality standards, but sales will be driven by FUJIFILM Irvine Scientific’s Life Sciences business unit.
 
FUJIFILM Irvine Scientific provides services for customers developing and manufacturing biopharmaceuticals, cell and gene therapy, and regenerative medicine for life science research and drug discovery. With a global network of sales and support operations across the U.S., Europe, and Asia, FUJIFILM Irvine Scientific aims to ensure efficient distribution of FUJIFILM Wako products. FUJIFILM Wako Pure Chemical Corp. has a long history in the markets they serve and will continue to sell directly to their customers in Asia.
 
“In 2020, FUJIFILM Irvine Scientific began selling iCell products from FUJIFILM Cellular Dynamics, and now we are excited to bring together the right mix of products from all of these Fujifilm teams, leveraging our collective expertise to offer our partners a breadth of life science solutions in one single destination,” said Yutaka Yamaguchi, general manager of Life Sciences Business Division, FUJIFILM Corporation. “We are listening to what our partners are asking for and FUJIFILM life sciences companies will continue working together to expand services needed for their future success in the field.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters